Diseases [C] » Infections [C01] » Virus Diseases » DNA Virus Infections » Herpesviridae Infections » Epstein-Barr Virus Infections
Diseases [C] » Infections [C01] » Virus Diseases » Tumor Virus Infections » Epstein-Barr Virus Infections
Description
Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY). MeSH
Hierarchy View
Subtype Terms (3)
Burkitt Lymphoma
164 drugs (96 approved, 68 experimental)
Infectious Mononucleosis
7 drugs (4 approved, 3 experimental)
Leukoplakia, Hairy
1 approved drug
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (4)
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (15)
Other Experimental Indicated Drugs (8)
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (31)
Blood and Marrow Transplant Clinical Trials Network
Children's Hospital Los Angeles
Children's National Medical Center
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
